These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 20308673)

  • 1. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.
    Le Deley MC; Delattre O; Schaefer KL; Burchill SA; Koehler G; Hogendoorn PC; Lion T; Poremba C; Marandet J; Ballet S; Pierron G; Brownhill SC; Nesslböck M; Ranft A; Dirksen U; Oberlin O; Lewis IJ; Craft AW; Jürgens H; Kovar H
    J Clin Oncol; 2010 Apr; 28(12):1982-8. PubMed ID: 20308673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.
    van Doorninck JA; Ji L; Schaub B; Shimada H; Wing MR; Krailo MD; Lessnick SL; Marina N; Triche TJ; Sposto R; Womer RB; Lawlor ER
    J Clin Oncol; 2010 Apr; 28(12):1989-94. PubMed ID: 20308669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
    Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
    J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
    Uren A; Toretsky JA
    Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of EWS-FLI1 fusion transcript in Ewing's sarcoma/peripheral primitive neuroectodermal tumors by one-step RT-PCR using paraffin-embedded tissues].
    Li F; Chang B; Li XX; Pang LJ; Lu HF; Wang J; Sun MH; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):328-31. PubMed ID: 15363317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
    de Alava E; Kawai A; Healey JH; Fligman I; Meyers PA; Huvos AG; Gerald WL; Jhanwar SC; Argani P; Antonescu CR; Pardo-Mindan FJ; Ginsberg J; Womer R; Lawlor ER; Wunder J; Andrulis I; Sorensen PH; Barr FG; Ladanyi M
    J Clin Oncol; 1998 Apr; 16(4):1248-55. PubMed ID: 9552022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
    Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF
    Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M; Smith R; Lessnick SL
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.
    de Alava E; Panizo A; Antonescu CR; Huvos AG; Pardo-Mindán FJ; Barr FG; Ladanyi M
    Am J Pathol; 2000 Mar; 156(3):849-55. PubMed ID: 10702401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing's sarcoma in vitro.
    Jully B; Vijayalakshmi R; Gopal G; Sabitha K; Rajkumar T
    BMC Cancer; 2012 Nov; 12():513. PubMed ID: 23145994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promiscuous partnerships in Ewing's sarcoma.
    Sankar S; Lessnick SL
    Cancer Genet; 2011 Jul; 204(7):351-65. PubMed ID: 21872822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of fusion subtype in Ewing sarcoma.
    Barr FG; Meyer WH
    J Clin Oncol; 2010 Apr; 28(12):1973-4. PubMed ID: 20308653
    [No Abstract]   [Full Text] [Related]  

  • 14. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
    Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
    Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples.
    de Alava E; Lozano MD; Patiño A; Sierrasesúmaga L; Pardo-Mindán FJ
    Diagn Mol Pathol; 1998 Jun; 7(3):152-7. PubMed ID: 9836070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells.
    Thompson AD; Teitell MA; Arvand A; Denny CT
    Oncogene; 1999 Sep; 18(40):5506-13. PubMed ID: 10523827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.
    Rao DD; Jay C; Wang Z; Luo X; Kumar P; Eysenbach H; Ghisoli M; Senzer N; Nemunaitis J
    Mol Ther; 2016 Aug; 24(8):1412-22. PubMed ID: 27166877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
    Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
    J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
    Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
    Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.